Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at bortezomib and CHOP chemotherapy for relapsed mantle cell lymphoma

Overview

Cancer types:

Blood cancers, Non-Hodgkin lymphoma (NHL)

Status:

Results

Phase:

Phase 2

Details

This trial was for mantle cell lymphoma that has not responded to treatment or had come back. Mantle cell lymphoma is a rare type of non Hodgkin Lymphoma. This trial was supported by Cancer Research UK.

Recruitment start: 20 June 2007

Recruitment end: 6 December 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Simon Rule

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Johnson and Johnson Pharmaceutical R+D

NIHR Clinical Research Network: Cancer

University Hospitals Plymouth NHS Trust

Other information

This is Cancer Research UK trial number CRUKE/07/056.

Last reviewed: 23 April 2018

CRUK internal database number: 878

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.